89 studies found for:    "factor V Leiden thrombophilia" OR "Thrombophilia"
Show Display Options
Rank Status Study
21 Completed Hypercoagulability After Breast Cancer Surgery
Conditions: Breast Cancer;   Blood Coagulation Disorders
Intervention: Procedure: Blood collection (pre and postoperative): plasma coagulation parameters
22 Unknown  ThrombElastoGraphic Haemostatic Status and Antiplatelet Therapy After Coronary Artery Bypass Graft Surgery
Conditions: Graft Patency;   Coronary Artery Bypass Grafting Surgery;   Hypercoagulability;   Thrombosis
Interventions: Drug: Clopidogrel+acetylsalicylic acid;   Drug: acetylsalicylic acid
23 Unknown  The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin
Conditions: Acute Coronary Syndrome;   Venous Thromboembolism;   Atrial Fibrillation;   Hypercoagulability
24 Unknown  Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Condition: Cancer
25 Completed Does Vitamin D Deficiency Associated With Hypercoagulability & Increased Thrombin Generation?
Condition: Chest Pain
26 Completed Biomarker Sub Study of the Compression Stockings to Prevent the Post-Thrombotic Syndrome (SOX) Trial
Condition: Deep Venous Thrombosis
27 Terminated Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)
Conditions: Venous Thromboembolism;   Fetal Death
Intervention: Other: Thrombophilia Testing
28 Completed Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies
Conditions: Pregnancy;   Iron Deficiency;   Iron Deficiency Anemia
Interventions: Dietary Supplement: Lattoglobina (Grunenthal) containing bLf;   Drug: FerroGrad by Abbott
29 Completed Evaluating the Relationship Between Blood Clotting Disorders, Inflammation, and Obesity in Individuals With Venous Disorders and Post-Thrombotic Syndrome
Conditions: Venous Thrombosis;   Venous Insufficiency
30 Completed Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test
Conditions: Factor V Leiden;   Factor II;   Thrombosis
31 Recruiting Low Weight Heparin prOphylaxis for Placental‐Mediated Complications of PrEgnancy
Conditions: High Risk Pregnant Women;   Placental Insufficiency;   Preeclampsia
Intervention: Drug: Enoxaparin
32 Recruiting A Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura
Condition: Acquired Thrombotic Thrombocytopenic Purpura
Interventions: Biological: caplacizumab;   Biological: placebo
33 Recruiting "Incidence and Consequences of Disorders of Glycosylation in Patients With Conotruncal and Septal Heart Defects"
Conditions: Congenital Heart Diseases;   Conotruncal Defects;   Congenital Disorder of Glycosylation;   Antithrombin III Deficiency
Intervention: Other: none intervention
34 Not yet recruiting Atenativ Effect on Uterine Blood Flow and Preeclampsia
Condition: Antithrombin III Deficiency
Intervention: Drug: Atenativ
35 Recruiting Phase 1 Dose Escalation, Single Dose Study to Assess Safety and Pharmacokinetics of BAX930 in Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Condition: Hereditary Thrombotic Thrombocytopenic Purpura (TTP)
Intervention: Drug: Recombinant ADAMTS13
36 Recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations
37 Recruiting Anti-thrombin III (ATIII) vs Placebo in Children (<7mo) Undergoing Open Congenital Cardiac Surgery
Condition: ATIII Deficiency
Interventions: Drug: Anti-thrombin III;   Other: Placebo
38 Not yet recruiting Octaplas Adult TTP Trial
Condition: Thrombotic Thrombocytopenic Purpura
Intervention: Biological: Octaplas
39 Enrolling by invitation A Pilot Study of N-acetylcysteine in Thrombotic Thrombocytopenia Purpura
Conditions: Purpura, Thrombotic Thrombocytopenic;   TTP
Intervention: Drug: N-Acetylcysteine
40 Withdrawn Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
Condition: Purpura, Thrombotic Thrombocytopenic
Interventions: Drug: Octaplas infusion and placebo (group 1);   Drug: Octaplas infusion and placebo (group 2)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years